Torben Vilsgaard

Inventure Capital A/S is a venture capital firm based in Aarhus, Denmark. Founded in 2006, the firm was established to manage several early-stage technology funds, namely INCUBA Venture, InnFond and Syddansk Kapital.

Borean Pharma ApS provides biopharmaceuticals drugs and protein engineering services. Its two main components of technology platform are CTLD library technology and trimerisation technology. The company was founded by Hans Christian Thøgersen and Michael Etzerodt in 1997 and is located in Aarhus, Denmark.

Action Pharma A/S is an R&D-focused biotech company located in the Nordic Medicon Valley area in Copenhagen, Denmark. Action Pharma was founded in 2000 and has a pipeline of 4 drug candidates in different stages of development, plus additional compounds in discovery and early preclinical development. Action Pharma pursues the discovery and development of new drugs and treatment concepts to treat cardiovascular diseases, inflammatory diseases and metabolic diseases, such as type-II diabetes and obesity. Its drug candidates are modified endogenous peptides with improved efficacy and small chemical entities targeted the melanocortin receptors. In disease models, its drug candidates have shown strong effects in treating and preventing inflammation and organ damage in conditions such as post-surgical organ dysfunction and acute myocardial infarction. A major focus for Action Pharma is treatment candidates for type-II diabetes, obesity and metabolic syndrome. Moreover, several drug candidates have shown effects in treating inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis and dermatitis.

ProtektorINVEST A/S provides investment solutions. The company invests in bonds, equities and REITs for both natural and legal entities. ProtektorINVEST A/S is located in Horsens, Denmark.

CellCure A/S manufactures organic chemical products. It focuses on the cultivation of human tumor-specific killer T lymphocytes with immunotherapeutic treatment of cancer. The company was founded in 2000 by Keld Kaltoft and is headquartered in Copenhagen, Denmark.

European Wind Investment A/S is a wind power company, which engages in the business of production and sale of electricity from wind turbines. The company also develops, builds and operates wind farms. It operates through two companies: TRE-FOR, a utility company, and EgnsINVEST, a capital management company. European Wind Investment was founded on November 30, 2007 and is headquartered in Horsens, Denmark.